Clinical Risk Factors of Chronic Renal Allograft Dysfunction.
- Author:
Ji Eun OH
;
Curie AHN
;
Jaeseok YANG
;
Ho Jun CHIN
;
Jin Suk HAN
;
Suhnggwon KIM
;
Jung Sang LEE
;
Sang Jun KIM
- Publication Type:Original Article
- Keywords:
Chronic graft dysfunction;
Risk factor;
Kidney transplantation
- MeSH:
Allografts*;
Cadaver;
Creatinine;
Delayed Graft Function;
Humans;
Incidence;
Kidney;
Kidney Transplantation;
Proteinuria;
Risk Factors*;
Seoul;
Tissue Donors;
Transplants
- From:Korean Journal of Nephrology
1998;17(4):603-613
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Chronic renal allograft dysfunction (CRAD) has been the rnost frequent cause of graft failure for last decade. Even in cycloporine era the incidence of CRAD has not changed. From Jan 1992 to Dec 1994 118 kidney transplants performed in Seoul National University Hospital had been entered into our database. All patients had been followed for at least 1 year. CRAD is defined if there had been progressive deterioration of renal function that was not explained by other causes and finally serum creatinine (Scr) had doubled from basal Scr after transplantation and has been maintained. Analyzed factors as follows; HLA misrnatch, living or cadaver transplant, ABO mismatch, acute rejecton (AR), frequency and timing of AR, donor age, recipient age, cold ischmic time, delayed graft function, proteinuria, infection. A CRAD has developed in 27 (23%) patients. The incidence of CRAD with time was analyzed by Kaplan-Meier survival analysis and compared with log-rank test. We concluded that in univariate anlaysis the risk factors are acute rejection, frequency of AR, AR after 3 months after tranplantation, age of recipient<15 and cold ischmic time> 40rnin for living transplants. Although HLAMM=0 significantly decreased the risk of CRAD (P<0.05), there was no difference in renal survival between groups of HLAMM>1. AR and HLAMM (HLAMM=O vs. HLAMM>1) were related each other (P=0.02).
